A lifestyle program for women with metastatic breast cancer
Official title: Every Day Counts: A lifestyle program for women metastatic breast cancer
Funded at Medical College of Wisconsin · NIH-11017029 · Data updated 2026-11-12
This study is creating a friendly program for women with metastatic breast cancer to help them feel better by encouraging exercise and healthy habits, aiming to improve their overall well-being and manage symptoms related to their treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | February 1, 2022 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $643,291 |
| NIH project number | 5R01CA258759-04 |
| Project ID | NIH-11017029 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with metastatic breast cancer who are seeking ways to manage their symptoms and improve their overall health.
✕Less likely to help
Patients with early-stage breast cancer or those not diagnosed with breast cancer may not receive any benefit from this research.
What this research studies
This research focuses on developing a lifestyle intervention program specifically for women with metastatic breast cancer (MBC) to help manage symptoms and improve their quality of life. The program aims to address adverse body composition changes caused by cancer treatments, such as increased adipose tissue and decreased muscle mass. By encouraging physical activity and healthy lifestyle choices, the research seeks to enhance overall well-being and potentially improve biomarkers related to cancer prognosis. Participants will engage in activities designed to increase strength and reduce symptoms associated with their condition.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and health outcomes for women living with metastatic breast cancer.
How similar studies have gone: Previous lifestyle interventions for early-stage breast cancer survivors have shown promising results, indicating that similar approaches may also benefit women with metastatic breast cancer.
Where this research is happening
-
Medical College of Wisconsin
Milwaukee, United States Active
Researchers
- Principal investigator: Stolley, Melinda R — Medical College of Wisconsin
- Study coordinator: Stolley, Melinda R
Related research
Other NIH-funded projects on the same topics.
-
Understanding FGFR1-amplified breast cancer to overcome endocrine resistance
This project explores why a type of breast cancer with FGFR1 changes stops responding to hormone therapy and looks for new combination treatments that may help patients live longer.
-
Oral fulvestrant as the next standard of care for ER+ metastatic breast cancer
A new oral formulation of fulvestrant is being tested to help people with ER-positive metastatic breast cancer have a longer, better-tolerated response to treatment.
-
Fit2ThriveMB: A digital activity program to help people with metastatic breast cancer feel better and stay active
A digital, at-home physical activity program designed for people with metastatic breast cancer to improve quality of life and daily functioning.
-
Acupuncture to ease symptoms for people with metastatic breast cancer
A clinical trial will test whether weekly acupuncture for 12 weeks can reduce symptom burden for people with metastatic breast cancer who are on standard therapy.
-
Predicting end-of-life timing to guide better care for metastatic breast cancer
A clinician-facing project tests a breast cancer prognostic tool in everyday oncology care to help guide conversations and timely hospice referrals for patients nearing the end of life.
-
Combining antibody-drug conjugates with mechanism-based therapies to treat metastatic triple-negative breast cancer
A research team is testing new combination strategies that pair antibody-drug conjugates with other targeted treatments to better treat metastatic triple-negative breast cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.